^○Yoko NAWATA¹, Taku YAMAGUCHI², Ryo FUKUMORI², Tsuyoshi NISHIOKU¹, Tsuneyuki YAMAMOTO² (1. Department of Pharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, 2. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University)

^○Keisuke MIZUO, Tomoka YAMAGUCHI, Satoshi WATANABE (Department of Legal Medicine, Sapporo Medical University, Sapporo, Japan)

^○Takumi NAKAJIMA¹, Kequan FU^{1, 2}, Yoshiaki MIYAMOTO¹, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China)

^○Yuka KUSUI¹, Kyosuke UNO^{1, 2}, Bin GE¹, Seiya MORISHITA¹, Shin-ichi MURAMATSU^{3, 4}, Atsumi NITTA¹ (1. Lab. of Pharmaceutical Therapy and Neuropharmacology,Department of Pharmaceutical Sciences,University of Toyama, Toyama, Japan, 2. Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, 3. Division of Neurological Gene Therapy, Open Inovation Center, Jichi Medical University, 4. Center for Gene & Cell Therapy, Institute of Medical Science, The University of Tokyo)

^○Nene KOIKE¹, Yasui HIROKI¹, Fumiko SEKIGUCH¹, Genzoh TANABE², Atsufumi KAWABATA¹ (1. Laboratory of Pharmacology Pathophysiology, Faculty of Pharmacy, Kindai University, Osaka, Japan, 2. Laboratory of Organic Chemistry, Faculty of Pharmacy, Kindai University, Osaka, Japan)

^○Naveen SHARMA, Min Ji KANG, Duc Toan PHAM, Quynh Dieu TRINH, Eun-Joo SHIN, Hyoung-Chun KIM (Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, Republic of Korea)

^○Naveen SHARMA, Min Ji KANG, Duc Toan PHAM, Quynh Dieu TRINH, Eun-Joo SHIN, Hyoung-Chun KIM (Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, Republic of Korea)

^○Ariyuki KAGAYA^{1, 2}, Ryotaro TSUKUE², Takashi SHIMIZU², Hidenobu ZENSHO², Tatsuya FURUSHOU² (1. KONUMA Memorial Institute of Addiction and Mental Health, 2. Senogawa Hospital)

^○Saeheon JANG (Department of psychiatry, Bongseng Memorial Hospital)

^○Saeheon JANG (Department of psychiatry, Bongseng Memorial Hospital)

^○Warot LAMYAI¹, Kitkawee PONO¹, Apichart SAENGSIN², Manit SRISURAPANONT³ (1. Nakhon Phanom Rajanagarindra Psychiatric Hospital, Department of Mental Health, Ministry of Public Health, Thailand, 2. Galyarajanagarindra Institute, Department of Mental Health, Ministry of Public Health, Thailand, 3. Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand)

^○Wenyu HSU^{1, 2, 3}, Tsung-Chieh LEE⁴, Hsien-Yuan LANE^{5, 6}, Yun-Tai CHEN⁴ (1. Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan, 2. Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan, 3. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, 4. Department of Chinese Medicine, Changhua Christian Hospital, Changhua, Taiwan, 5. Department of Psychiatry & Brain Disease Research Center, China Medical University and Hospital, Taichung, Taiwan, 6. Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan)

^○Junya FUJINO^{1, 2}, Ryosaku KAWADA², Kosuke TSURUMI², Hideaki TAKEUCHI², Shisei TEI^{1, 2, 3, 4}, Takuro MURAO², Ariyoshi TAKEMURA², Nobumasa KATO¹, Toshiya MURAI², Hidehiko TAKAHASHI^{1, 2, 5} (1. Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. Institute of Applied Brain Sciences, Waseda University, Saitama, Japan, 4. School of Human and Social Sciences, Tokyo International University, Saitama, Japan, 5. Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan)

^○Daun SHIN¹, Minkyung PARK², Jiyoon LEE², A Ruem CHOI², Sun Ju CHUNG², Bomi KIM², Myung Hun JUNG³, Dai Jin KIM⁴, Jung-Seok CHOI^{2, 5} (1. Department of Neuropsychiatry, Seoul National University Hospital, 2. Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea, 3. Department of Psychiatry, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea, 4. Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea, 5. Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Seoul, Republic of Korea)

^○Chang-Chih HUANG¹, San-Yuan HUANG² (1. Department of psychiatry, Taipei Tzu-Chi Hospital, 2. Tri-Service General Hospital)

^○Seii OHKA¹, Daisuke NISHIZAWA¹, Junko HASEGAWA¹, Naomi SATO^{2, 3}, Hidetaka YAMADA³, Fumihiko TANIOKA⁴, Haruhiko SUGIMURA³, Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Clinical Nursing, Hamamatsu University School of Medicine, Hamamatsu, Japan., 3. Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan., 4. Department of Pathology, Iwata City Hospital, Iwata, Japan.)

^○Joungwook SEO¹, In Soo RYU¹, Minhan KA¹, Ji Sun KIM¹, Woo Hyun KIM¹, Eun Young JANG¹, Ri-Na LIM¹, Tae Wan KIM¹, Dae Young LEE² (1. Pharmacology & Drug Abuse Group, Korea Institute of Toxicology, Daejeon, South Korea, 2. Department of Herbal Corp Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, South Korea )

^○Shanta THAPA^{1, 2}, Yuko SADAMURA^{1, 2}, Ryota MIZUNUMA¹, Yuki KAMBE¹, Akira HIRASAWA³, Kuzuo NAKAMOTO⁴, Shogo TOKUYAMA⁴, Kazunori ARITA², Koji YOSHIMOTO², Atsuro MIYATA¹, Tatsuki OYOSHI², Takashi KURIHARA¹ (1. Department of Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 2. Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, 3. Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, 4. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University, Hyogo, Japan)

^○Yoki NAKAMURA^{1, 2}, Dilyan I. DRYANOVSKI³, Carl R. LUPICA³, Tsung-Ping SU² (1. Department of Pharmacology, Graduate School of Biomedical & Health Sciences, Hiroshima University, 2. Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, 3. Electrophysiology Research Section, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse)

^○Hideaki KATO, Minoru TSUJI, Kazuya MIYAGAWA, Hiroshi TAKEDA (Dept. Pharmacol., Sch. Pharm., Int. Univ. Health and Welfare, Tochigi, Japan)

^○Takahiro MASUDA¹, Tadafumi KATO², Jun ISHIGOOKA³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. RIKEN Brain Science Institute, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Takahiro MASUDA¹, Jun ISHIGOOKA², Tadafumi KATO³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. Institute of CNS Pharmacology, Japan, 3. RIKEN Brain Science Institute, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Jun ISHIGOOKA¹, Tadafumi KATO², Mari MIYAJIMA³, Kei WATABE³, Takahiro MASUDA³, Teruhiko HIGUCHI^{4, 5} (1. Institute of CNS Pharmacology, Japan, 2. RIKEN Brain Science Institute, Japan, 3. Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Yen-Feng LIN¹, Shih-Ku LIN^{2, 3} (1. Balance Psychiatric Clinic, Hsinchu City, Taiwan, 2. Department of Psychiatry, Taipei City Hospital and Psychiatric Center, Taipei City, Taiwan, 3. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei City, Taiwan)

^○Nak-Young KIM, Young Sup WOO, Won-Myong BAHK (Department of Psychiatry, The Catholic University of Korea )

^○Kunihiro IWAMOTO¹, Akiko YAMAGUCHI¹, Masahiko ANDO², Kiyoshi FUJITA³, Motonori YOKOYAMA⁴, Tsuyoshi AKIYAMA⁵, Yoshio IGARASHI⁶, Reiji YOSHIMURA⁷, Norio OZAKI¹ (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan, 2. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Aichi, Japan, 3. Department of Psychiatry, Okehazama Hospital, Aichi, Japan, 4. Sapporo Ekimae Clinic, Sapporo, Japan, 5. Department of Psychiatry, NTT Medical Center Tokyo, Tokyo, Japan, 6. Medical Care Toranomon, Tokyo, Japan, 7. Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan)

^○Fumitaka NAKANO¹, Kyosuke UNO^{2, 3}, Kazuki TOKORO², Hiroki TAKEMOTO¹, Atsumi NITTA^{1, 2} (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan, 3. Laboratory of molecular pharmacology faculty of pharmaceutical sciences, University of Setsunan, Osaka, Japan)

^○Cynthia SIU¹, Mary Miu Yee WAYE², Shitao RAO^{2, 3, 4}, Marco Ho Bun LAM⁴, Ji-hui ZHANG⁴, Stephen Kwok Wing TSUI³, Yun Kwok WING⁴ (1. COS and Associates Ltd., Hong Kong SAR, China, 2. The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China, 3. School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China, 4. Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China)

^○MuHong CHEN^{1, 2}, Ya-Mei BAI^{1, 2}, Tung-Ping SU^{1, 2} (1. Department of Psychiatry, Taipei Veterans General Hospital, 2. Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan)

^○Yanli DU¹, Jianbo HU², Tingting HUANG¹, Jianbo LAI², Weihua ZHANG¹, Chao LI¹, Zhongya XU³, Hetong ZHOU², Shaohua HU², Liemin RUAN⁴ (1. Zhejiang University School of Medicine, Hangzhou, China, 2. Department of Psychiatry, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 3. Department of Psychiatry, Jiaxing Kangci Hospital, Jiaxing, China, 4. Department of Psychosomatics, Ningbo First Hospital, Ningbo, China)

^○Shoko TSUCHIMINE¹, Kotaro HATTORI¹, Miho OTA¹, Shinsuke HIDESE¹, Toshiya TERAISHI¹, Daimei SASAYAMA¹, Hiroaki HORI¹, Takamasa NODA², Sumiko YOSHIDA², Fuyuko YOSHIDA¹, Hiroshi KUNUGI¹ (1. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 2. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry)

^○Sayuri ISHIWATA¹, Hisayoshi TAKAI², Favour OMILEKE¹, Kotaro HATTORI^{1, 3}, Fuyuko YOSHIDA¹, Shinsuke HIDESE¹, Junko MATSUO¹, Ikki ISHIDA¹, Moeko HIRAISHI¹, Hiroshi KUNUGI¹ (1. Deparmtent of Mental Disorder Research, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Kawasaki City Institute for Public Health, Kawasaki, Japan, 3. Medical Genom Center, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○Minah KIM^{1, 2}, Seoyeon KWAK³, Youngwoo Bryan YOON⁴, Yoo Bin KWAK³, Taekwan KIM³, Kang Ik K. CHO³, Tae Young LEE³, Jun Soo KWON^{1, 2, 3, 5} (1. Department of Neuropsychiatry, Seoul National University Hospital, 2. Department of Psychiatry, Seoul National University College of Medicine, 3. Department of Brain and Cognitive Sciences, Seoul National University College of Natural Science, 4. Department of Psychiatry, Washington University in St. Louis, 5. Institute of Human Behavioral Medicine, SNU-MRC)

^○Takuya HASHIMOTO¹, Hirokazu KUMAZAKI², Keiichiro MUKAI¹, Masahiro MIYAUCHI¹, Kyousuke YAMANISHI¹, Naomi MATSUURA³, Hisato MATSUNAGA¹ (1. Department of Neuropsychiatry Hyogo college of Medicine, Hyogo, Japan, 2. Department of Preventive intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 3. Special Education Course, Faculty of Education, Mie University, Tsu, Japan)

^○Po-Han CHOU^{1, 2}, Jui-Cheng CHEN³ (1. Department of Psychiatry, China Medical Hsinchu Hospital, Taiwan., 2. Department of Psychiatry, China Medical Hospital, Taichung, Taiwan., 3. Department of Neurology, China Medical Hsinchu Hospital, Taiwan.)

^○Anri WATANABE, Takashi NAKAMAE, Nobutaka John AYANI, Junko ONO, Nozomu OYA, Jin NARUMOTO (Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan)

^○Nozomi ASAOKA^{1, 2}, Naoya NISHITANI¹, Haruko KINOSHITA¹, Yuma NAGAI¹, Hikari HATAKAMA¹, Kazuki NAGAYASU¹, Hisashi SHIRAKAWA¹, Takayuki NAKAGAWA³, Chihiro YABE-NISHIMURA², Shuji KANEKO¹ (1. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, 2. Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan)

^○Kazutaka OHI^{1, 2}, Takeshi OTOWA³, Mihoko SHIMADA^{4, 5}, Tsukasa SASAKI⁶, Hisashi TANII^{7, 8} (1. Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 2. Department of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan, 3. Graduate School of Clinical Psychology, Professional Degree Program in Clinical Psychology, Teikyo Heisei University, Tokyo, Japan, 4. Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 5. Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 6. Department of Physical and Health Education, Graduate School of Education, The University of Tokyo, Japan, 7. Center for Physical and Mental Health, Mie University, Mie, Japan, 8. Graduate School of Medicine, Department of Health Promotion and Disease Prevention, Mie University, Mie, Japan)

^○Taro SASAKI¹, Takashi WATANABE^{1, 4}, Yoshimasa INOUE¹, Hazuki SASAKI¹, Masataka SHINOZAKI¹, Akiko AOKI¹, Yuki HAYASHI¹, Kazuko KATO³, Zinichi KURODA², Norio FURUKORI¹, Kazutaka SHIMODA¹ (1. Department of Psychiatry Dokkyo Medical Universitym, Tochigi, Japan, 2. Tochigi Prefectural Okamotodai Hospital, 3. Sakurara Psychosomatic Medicine, 4. Keijikai Kikuchi Hospital)

^○Akira YOSHIMI^{1, 2, 3}, Iyo MURAKAWA¹, Hirotake HIDA^{1, 2}, Sho HASEGAWA¹, Takahiro ITO¹, Mizuki UCHIDA¹, Itaru KUSHIMA^{3, 4}, Norio OZAKI³, Yukihiro NODA^{1, 2, 3} (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, Nagoya, Japan, 2. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 3. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan, 4. Institute for Advanced Research, Nagoya University, Nagoya, Japan)

^○Yukie KAWAHARA¹, Yuuki HANADA¹, Yosinori OHNISHI¹, Takahide SHUTO¹, Mahomi KUROIWA¹, Naoki SOTOGAKU¹, Hiroshi KAWAHARA², Akinori NISHI¹ (1. Dept. of Pharmacology, Kurume University School of Medicine, Fukuoka, Japan, 2. Dept. of Dental Anesthesiology, School of Dental Medicine, Tsurumi University, Kanagawa, Japan )

^○Yuki HONSHUKU, Ryoki SAITO, Takuji SOGA, Natsuko HITORA-IMAMURA, Masabumi MINAMI (Lab. of Pharmacology, Department of Pharmacy, Hokkaido University, Hokkaido, Japan)

^○Yuliana AZIS, Muhammad Faisal IDRUS, Saidah SYAMSUDDIN, Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia)

^○Won KIM (Department of Psychiatry, Seoul Paik Hospital, Inje University)

^○Shuichi UEDA¹, Yasushi KAWAMATA², Ayuka EHARA¹, Tsuyoshi YAMAGUCHI¹, Yoshiteru SEO³, Kazutaka SHIMODA² (1. Department of Histology and Neurobiology, Dokkyo Medical University School of Medicine, Tochigi, Japan, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan, 3. Department of Regulatory Physiology, Dokkyo Medical University School of Medicine, Tochigi, Japan)

^○Hiroko IKEDA¹, Aimi YAMAGISHI¹, Naomi YONEMOCHI¹, Takatsune SHIMIZU², Akihiro MUTO², Junzo KAMEI³ (1. Department of Pathophysiology and Therapeutics, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan, 2. Department of Pathophysiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan, 3. Department of Biomolecular Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan)

^○Hideo HAGIHARA, Hirotaka SHOJI, Yoshihiro TAKAMIYA, Tsuyoshi MIYAKAWA (Division of Systems Medicsl Science, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan)

^○Ryuto HARA, Tatsuhiro TAKEHARA, Daiki TAKAHASHI, Saki MINAMI, Taiju AMANO, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan)

^○Shuhei KAYASHIMA^{1, 2}, Hiroshi KUNIISHI¹, Kazumi YOSHIZAWA², Masayuki SEKIGUCHI³, Mitsuhiko YAMADA¹ (1. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Laboratory of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan, 3. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○Mikio YOSHIDA¹, Sho HASEGAWA¹, Mizuki UCHIDA¹, Yoji UCHIDA¹, Akihiro MOURI^{2, 6}, Akira YOSHIMI^{1, 3}, Masayoshi MISHINA⁴, Norio OZAKI³, Toshitaka NABESHIMA^{5, 6}, Yukihiro NODA^{1, 3, 6} (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, Nagoya, Japan, 2. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Aichi, Japan, 3. Department of Psychiatry, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 4. Brain Science Laboratory, The Research Organization of Science and Technology, Ritsumeikan University, Shiga, Japan, 5. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 6. Japanese Drug Organization of Appropriate Use and Research, Nagoya, Japan )

^○Kazuki TOKORO¹, Kyosuke UNO^{1, 2}, Shin-ichi MURAMATSU^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan., 2. Laboratory of molecular pharmacology faculty of pharmaceutical science, University of Setsunan, Osaka, Japan, 3. Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke, JAPAN, 4. Center for Gene and Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, JAPAN)

^○MuHong CHEN^{1, 2}, Hui-Ju WU¹, Tung-Ping SU^{1, 2}, Cheng-Ta LI^{1, 2}, Ya-Mei BAI^{1, 2}, Wei-Chen LIN^{1, 2}, Chih-Ming CHENG^{1, 2} (1. Department of Psychiatry, Taipei Veterans General Hospital, 2. Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan)

^○MuHong CHEN^{1, 2}, Hui-Ju WU¹, Tung-Ping SU^{1, 2}, Cheng-Ta LI^{1, 2}, Ya-Mei BAI^{1, 2}, Wei-Chen LIN^{1, 2}, Chih-Ming CHENG^{1, 2} (1. Department of Psychiatry, Taipei Veterans General Hospital, 2. Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan)

^○Ming-Huan CHAN¹, Mei-Yi LEE², Shao Tsu CHEN³, Chung-Pin HSIEH², Hwei-Hsien CHEN² (1. Institute of Neuroscience, National Chengchi University, 2. Center for Neuropsychiatric Research, National Health Research Institutes, 3. Department of Psychiatry, Tzu Chi University)

^○Takahide SHUTO, Mahomi KUROIWA, Naoki SOTOGAKU, Yukie KAWAHARA, Yoshinori OHNISHI, Yuuki HANADA, Akinori NISHI (Department of Pharmacology, Kurume University School of Medicine, Fukuoka, Japan)

Andi Jayalangkara TANRA, Hawaidah MADEALI, Mayamariska SANUSI, ^○Dwiwahyu Ningsih SUNARTO, Saidah SYAMSUDDIN, Sonny Teddy LISAL (University of Hasanuddin)

^○Frederick M. JACOBSEN^{1, 2}, Lillian COMAS-DIAZ^{1, 2} (1. The George Washington University School of Medicine, 2. Transcultural Mental Health Insitute)

^○Maiko HAYASHIDA¹, Tsuyoshi MIYAOKA¹, Tomoko ARAKI¹, Toshiko MINAMOTO², Sadayuki HASHIOKA¹, Rei WAKE¹, Masatoshi INAGAKI¹ (1. Department of Psychiatry, Faculty of Medicine, Shimane University, 2. Department of Obstetrics, Faculty of Medicine, Shimane University)

^○Kazuya MIYAGAWA, Atsumi MOCHIDA-SAITO, Kazuhiro KUROKAWA, Hidenao KIMIJIMA, Minoru TSUJI, Hiroshi TAKEDA (Departmnent of Pharmacology, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan)

^○Satoshi DEYAMA¹, Kohei ISHIMURA², Hayato FUKUDA^{2, 3}, Satoshi SHUTO², Masabumi MINAMI⁴, Katsuyuki KANEDA¹ (1. Lab. of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan, 2. Lab. of Organic Chemistry for Drug Development, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan, 3. Pharmaceutical Organic Chemistry Lab., Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, 4. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan)

^○Akiyoshi SAITOH¹, Daisuke YAMADA¹, Jun-Ichiro OKA¹, Hiroshi NAGASE² (1. Lab Pharmacol, Fac Pharm Sci, Tokyo Univ of Science, Chiba, Japan, 2. IIIS, University of Tsukuba, Ibaraki, Japan )

^○Tsubasa IIDA¹, Kazuo KUNISAWA¹, Sei SAITOH², Aika KOSUGE¹, Wulaer BOLATI^{3, 4}, Willy Jaya SUENTO^{4, 5}, Yasuko YAMAMOTO⁴, Akihiro MOURI¹, Kuniaki SAITO^{3, 4}, Toshitaka NABESHIMA³ (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 2. Department of Anatomy II and Cell Biology, Fujita Health University School of Medicine, Aichi, Japan., 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 4. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 5. Department of Psychiatry, Hasanuddin University, South Sulawesi, Indonesia)

^○Aika KOSUGE¹, Kazuo KUNISAWA¹, Tsubasa IIDA¹, Wulaer BOLATI^{2, 3}, Willy Jaya SUENTO^{3, 4}, Yasuko YAMAMOTO³, Akihiro MOURI¹, Kuniaki SAITO^{2, 3}, Toshitaka NABESHIMA² (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 4. Department of Psychiatry, Hasanuddin University, South Sulawesi, Indonesia.)

^○Kazuhiro KUROKAWA, Minoru TSUJI, Kazuya MIYAGAWA, Atsumi MOCHIDA-SAITO, Hiroshi TAKEDA (Department of Pharmacology, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan)

^○Takahiro ITO¹, Yuka HIRAMATSU¹, Mizuki UCHIDA¹, Akira YOSHIMI¹, Norio OZAKI², Yukihiro NODA^{1, 2} (1. Division of Clinical Sciences and Neuropsychopharmacology, Meijo University Faculty and Graduate School of Pharmacy, Nagoya, Japan, 2. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan)

^○Ryota TAKANO^{1, 2}, Michio NOMURA¹ (1. Division of Cognitive Psychology, Graduate School of Education, Kyoto University, 2. Japan Society for the Promotion of Science)

^○Seung-Hoon LEE, Changsu HAN, Cheolmin SHIN, Hyounwook KIM ( Department of Psychiatry, College of Medicine, Korea University)

^○EunJee KIM, JiSun KIM, WanJoon KWON, SeHoon SHIM (Department of Psychiatry, Soonchunhyang University Cheonan Hospital)

^○Hsuan CHANG^{1, 2}, Kai-Jen CHENG^{1, 2}, Wan-Fu TSAI¹, Tzu-Hua WU¹ (1. Division of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, 2. New Taipei City Pharmacists Association, New Taipei City, Taiwan)

^○Jing LU, Chao Bo HUANG, Ting Ting MOU, Mei Hai LI, Hua Shao HU (Department of Neurobiology; Zhejiang Province Key Laboratory of Mental Disorder’s Management, Zhejiang University School of Medicine)

^○Hajime MIYANISHI¹, Kyosuke UNO^{1, 2}, Shin-ichi MURAMATSU^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, Toyama Unuversity, Toyama, 2. Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan, 3. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 4. Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Hiromi ABE^{1, 2}, Naoto KAJITANI¹, Mami OKADA-TSUCHIOKA ¹, Wataru OMORI¹, Masahide YATSUMOTO², Minoru TAKEBAYASHI^{1, 3} (1. Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, 2. Department of Pharmacy, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Japan, 3. Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan)

^○Yuma NAGAI¹, Kazuki NAGAYASU¹, Konomi MASUNAKA², Yukio AGO^{2, 3}, Atsushi KASAI², Hisashi SHIRAKAWA¹, Takanobu NAKAZAWA^{2, 4}, Hitoshi HASHIMOTO^{2, 5, 6, 7}, Shuji KANEKO¹ (1. Department of Molecular Pharmacology Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, 2. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. Laboratory of Molecular Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 4. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 5. Molecular Research Center of Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, 6. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 7. Open and Transdisciplinary Research Intiatives, Osaka University, Osaka, Japan)

^○Yosuke YAMAWAKI^{1, 2}, Satomi SHIRAWACHI², Munechika TAKAISHI², Shigeto YAMAWAKI³, Takashi KANEMATSU^{2, 4} (1. Department of Advanced Pharmacology, Daiichi University of Pharmacy, Fukuoka, Japan, 2. Department of Cellular and Molecular Pharmacology Institute of Biomedical and Health Sciences Hiroshima University, Hiroshima, Japan, 3. Office of Industry-Academia-Government and Community Collaboration Institute of Biomedical and Health Sciences Hiroshima Univesity, Hiroshima, Japan, 4. Department of Cell Biology and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan)

^○Saya ARAKAKI, Keisuke SAKASAI, Natsuko HITORA-IMAMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan)

^○Minoru TSUJI, Kazuhiro KUROKAWA, Kazuya MIYAGAWA, Atsumi MOCHIDA-SAITO, Hiroshi TAKEDA (Department of Pharmacology, School of Pharmacy, International University of Health and Welfare)

^○Daiki UEDA¹, Aimi YAMAGISHI¹, Naomi YONEMOCHI¹, Junzo KAMEI², Hiroko IKEDA¹ (1. Department of Pathophysiology and Therapeutics, Hoshi University, Tokyo, Japan, 2. Department of Biomolecular Pharmacology, Hoshi University, Tokyo, Japan)

^○Kyung Joon MIN, Hyunchan HWANG, Sol I. KIM, Han Il. RYOO, Doug Hyun HAN, Sun Mi KIM (Department of Psychiatry, Chung-Ang University Hospital, Seoul, Korea)

^○Chi-Hyun CHOI¹, Jung LEE², Kyung Hwa LEE³, Soon-Beom HONG³, Seong-Hae KIM³, Ji-Youn HAN³, Jun Won KIM⁴, Soo Churl CHO⁵, Jae-Won KIM³ (1. Department of psychiatry, SMG - SNU Boramae Medical Center, 2. Pediatric Palliative Care Team, Integrative Care Hub, Seoul National University Children's Hospital, 3. Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital, 4. Department of Psychiatry, Catholic University of Daegu School of Medicine, 5. Department of Psychiatry, Armed Forces Capital Hospital)

^○Young Sook KWACK (Department of Psychiatry, Jeju National University)

^○Tien-Yu CHEN^{1, 3}, Wei-Chung MAO², Nian-Sheng TZENG¹, Cheryl Ch YANG³, Terry Bj KUO³, Chi-Hsiang CHUNG⁴, Wu-Chien CHIEN⁴ (1. Department of Psychiatry, Tri-Service General Hospital; School of Medicine, National Defense Medical Center, Taipei, Taiwan, 2. Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan, 3. Institute of brain science, National Yang-Ming University, Taipei, Taiwan, 4. Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan)

^○Kazumaro OKINO^{1, 2}, Hirohisa SUZUKI^{1, 2}, Hiroto TOMIOKA^{1, 2}, Hiroki YAMADA^{1, 2}, Shinji NOZAKI^{1, 2}, Akira IWANAMI², Astuko INAMOTO^{1, 2} (1. Mental Care Center, Showa University Northen Yokohama Hospital, Kanagawa, Japan, 2. Department of Neuropsychiatry, Showa University School of Medicine)

^○Jong-Hyun JEONG, Ji-Hyeon LEE, Sung-Min KIM, Seung-Chul HONG, Ho-Jun SEO, Tae-Won KIM (Department of Psychiatry, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea)

^○Bolati WULAER^{1, 2}, Kazuo KUNISAWA³, Willy Jaya SUENTO^{2, 4}, Tsubasa IIDA³, Aika KOSUGE³, Atsumi NITTA⁵, Akihiro MOURI³, Kuniaki SAITO^{1, 2}, Toshitaka NABESHIMA¹ (1. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 4. Department of Psychiatry, Hasanuddin University Faculty of Medicine, South Sulawesi, Indonesia, 5. Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan)

^○Miho TANAKA^{1, 2, 3}, Yoshimi KAGA², Yuka SHIRAKAWA², Masumi INAGAKI² (1. Department of Neuropsychiatry, The University of Tokyo Hospital, 2. Department of Developmental Disorders, National Institute of Mental Health, NCNP, 3. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science)

^○Fukie YAOITA¹, Masahiro TSUCHIYA², Yuichiro ARAI³, Takeshi TADANO⁴, Koichi TAN-NO¹ (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Miyagi, Japan, 2. Department of Nursing, Tohoku Fukushi University, Miyagi, Japan, 3. Tokyo Ariake University of Medical and Health Science, Tokyo, Japan, 4. Complementary and Alternative Medicine Clinical Research and Development, Graduate School of Medicine Sciences, Kanazawa University, Ishikawa, Japan)

^○Ikuko YAMADA, Tomoko KUSHIDA, Ikuo MIURA, Tamio FURUSE, Masaru TAMURA (Technology and Development Team for Mouse Phenotype Analysis, RIKEN BioResource Research Center, Tsukuba, Japan)

^○Tamio FURUSE¹, Ikuko YAMADA¹, Tomoko KUSHIDA¹, Ikuo MIURA¹, Shinya AYABE¹, Atsushi YOSHIKI¹, Hidenori YAMASUE², Shigeharu WAKANA³, Masaru TAMURA¹ (1. RIKEN BioResource Research Center, 2. Department of Psychiatry, Hamamatsu University School of Medicine, 3. Foundation for Biomedical Research and Innovation at Kobe)

^○Ervana Ikha YUSNITA¹, Lucky Saputra TAN², Veranita - PANDIA² (1. RSUD dr. H.M Rabain Muara Enim, Padjadjaran University, 2. Padjadjaran Univeristy)

^○Wenkai LIN¹, Bin CHEN¹, Yi WANG¹, Cenglin XU¹, Ying WANG¹, Liying CHEN¹, Heming CHENG¹, Lingyu XU¹, Tingting HU¹, Junli ZHAO¹, Ping DONG¹, Yi GUO², Shihong ZHANG¹, Shuang WANG², Yudong ZHOU¹, Weiwei HU¹, Zhong CHEN^{1, 2} (1. Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Basic Medical Sciences, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China, 2. Epilepsy Center, Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)

^○Kamiyu OGYU^{1, 2}, Shin KUROSE¹, Masaru MIMURA¹, Hiroyoshi TAKEUCHI¹ (1. Department of Neuropsychiatry, School of Medicine, Keio University, 2. National Hospital Organization Shimofusa Psychiatric Medical Center)

^○Liying CHEN¹, Yi WANG¹, Cenglin XU¹, Yingwei XU¹, Ying WANG¹, Heming CHENG¹, Fan FEI¹, Zhong CHEN^{1, 2} (1. Department of Pharmacology, Key laboratory of Medical Neurobiology of the Ministry of Health of China, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China, 2. Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China)

^○Naofumi KUNISAWA¹, Tadao SERIKAWA^{1, 2}, Saki SHIMIZU¹, Masaki KATO¹, Higor A IHA¹, Masato KINBOSHI¹, Hisao NISHIKAWA³, Yu SHIRAKAWA³, Masashi SASA⁴, Yukihiro OHNO¹ (1. Department of Pharmacology, Osaka University of Pharmacological Sciences, Osaka, Japan, 2. Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. KAC Co. Ltd, Kyoto, Japan, 4. Nagisa Clinic, Osaka, Japan)

^○Heming CHENG, Yi WANG, Zhong CHEN (Deparment of Pharmacology, Zhejiang University)

^○Toshinari MITSUOKA^{1, 3}, Kenji HANAMURA¹, Noriko KOGANEZAWA¹, Ruri KIKURA-HNAJIRI², Tomoaki SHIRAO¹, Yuko SEKINO³ (1. Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, 2. Division of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, 3. Endowed Laboratory of Human Cell-Based Drug Discovery, Graduate School of Pharmaceutical Sciences, The University of Tokyo)

^○Masayo FUJITA¹, Yukiko OCHIAI^{1, 2}, Taishi Clark TAKEDA¹, Yoko HAGINO¹, Kazuto KOBAYASHI³, Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 3. Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University )

^○Kento IGARASHI^{1, 2}, Kazuo TOMITA^{1, 2}, Koh-ichi TANAKA^{1, 2}, Yoshikazu KUWAHARA^{1, 3}, Nobuyoshi NISHIYAMA², Akihiro KURIMASA³, Tomoaki SATO¹ (1. Lab. of applied phapharmacology, Graduate school of medical and dental sciences, Kagoshima University, Kagoshima, Japan, 2. Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan, 3. Department of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan)

^○Yukiko OCHIAI^{1, 2}, Masayo FUJITA¹, Yoko HAGINO¹, Kazuto KOBAYASHI³, Ryoichi OKIYAMA², Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 3. Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University)

^○Mizuki UCHIDA¹, Erika OTA¹, Akira YOSHIMI¹, Shinji KITAGAKI², Norio OZAKI³, Tomomi AIDA⁴, Kohichi TANAKA⁴, Yukihiro NODA¹ (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2. Medicinal Chemistry, Meijo University Faculty of Pharmacy, Nagoya, Japan, 3. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan, 4. Laboratory of Molecular Neuroscience, Medical Research Institute, Tokyo Medical and Dental University (TMD), Tokyo, Japan)

^○Moe NIIJIMA¹, Akihiro MOURI^{1, 4}, Tomoaki TESHIGAWARA², Kazuo KUNISAWA¹, Hisayoshi KUBOTA¹, Mami HIRAKAWA¹, Yuko MORI², Masato HOSHI², Yasuko YAMAMOTO², Toshitaka NABESHIMA^{3, 4}, Kuniaki SAITO^{2, 4} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, 4. Japanese Drug Organization of Appropriate Use and Research)

^○Masaki KATO, Naofumi KUNISAWA, Saki SHIMIZU, Yuika ISHIKURA, Natsuki HIRATA, Mizuki YASUNAGA, Yukihiro OHNO (Dept. Pharmacol., Osaka Univ. Pharm. Sci., Osaka, Japan)

^○Ikuko MIYAZAKI¹, Masato ASANUMA¹, Shinki MURAKAMI¹, Ryo KIKUOKA^{1, 2}, Nami ISOOKA¹, Chiharu SOGAWA³, Norio SOGAWA⁴, Yoshihisa KITAMURA² (1. Dept. of Med. Neurobiol., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 2. Dept. of Clin. Pharm., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 3. Dept. of Dent. Pharmacol., Okayama Univ. Grad. Sch. of Med., Dent. & Pharmaceut. Sci., 4. Dept. of Dent. Pharmacol., Matsumoto Dent. Univ.)

^○Eunjeong LEE¹, KwangHun LEE¹, Kyung-Phil KWAK^{1, 2} (1. Department of Psychiatry, college of medicine, Deongguk university, Korea, 2. Provincial Dementia Center, Kyungsangbuk-do)

^○Shinichiro OCHI¹, Aya SANTA², Takaaki MORI¹, Jun-ichi IGA¹, Shu-ichi UENO¹ (1. Department of Neuropsychiatry, Ehime University Graduate School of Medicine, Ehime, Japan, 2. Nursing home Galilee)

^○Naoki TAKADA, Yoki NAKAMURA, Kazue NAKASHIMA, Norimitsu MORIOKA (Department of Pharmacology, Graduate school of Biomedical & Health Sciences, Hiroshima University)

^○Junichi IGA, Yuta YOSHINO, Yu FUNAHASHI, Shunsuke NAKATA, Yuki OZAKI, Kiyohiro YAMAZAKI, Taku YOSHIDA, Takaaki MORI, Yoko MORI, Shinichiro OCHI, Shu-ichi UENO (Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine)

^○Md. Ali Bin SAIFULLAH¹, Okiru KOMINE², Akira SOBUE², Koji YAMANAKA², Hiroyuki MIZOGUCHI¹ (1. Research Center for Next-Generation Drug Development, Research Institute of Environmental Medicine, Nagoya University, 2. Department of Neuroscience and Pathology, Research Institute of Environmental Medicine, Nagoya University)

^○Yasufumi SAKAKIBARA¹, Michiko SEKIYA¹, Takashi SAITO², Takaomi C. SAIDO², Koichi M. IIJIMA¹ (1. Department of Alzheimer's Disease Research, National Center for Geriatrics and Gerontology, Aichi, Japan, 2. Laboratory of Proteolytic Neuroscience, RIKEN CBS, Saitama, Japan)

^○Tomoko TANAKA¹, Shinobu HIRAI¹, Masato HOSOKAWA², Takashi SAITO³, Takaomi SAIDO³, Masato HASEGAWA², Haruo OKADO¹ (1. Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, 2. Department of Dementia and Higher brain FUnction, Tokyo Metropolitan Institute of Medical Science, 3. Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science)

^○Daisuke JOHO¹, Takeru SUZUKI¹, Masaya FUJIWARA², Takashi SAITO³, Takaomi SAIDO³, Masaki KAKEYAMA^{1, 2, 4} (1. Lab. of Environmental Brain Science, Graduate School of Human Sciences, Waseda University, Saitama, Japan, 2. Research Institute for Environmental Medical Sciences, Waseda University, Saitama, Japan, 3. Lab. for Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama, Japan, 4. Lab. of Environmental Brain Science, Faculty of Human Sciences, Waseda University, Saitama, Japan)

^○Wang FAN¹, Kyohei YAMADA¹, Kyosuke UNO^{1, 2}, Hiroshi MARUYAMA¹, Noboru MOTOYAMA², Wakako MARUYAMA³, Atsumi NITTA¹ (1. Department of pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Department of Health and Nutrition Faculty of Psycological & Physical Science Aichi Gakuin University, Aichi, Japan, 3. Laboratory of Biochemistry, Department of Human Nutrition, Sugiyama Jogakuen University, Aichi, Japan)

^○Takeru SUZUKI¹, Daisuke JOHO¹, Masaki KAKEYAMA^{1, 2, 3} (1. Lab. of Environmental Brain Science, Graduate School of Human Sciences, Waseda University, Saitama, Japan, 2. Research Institute for Environmental Medical Sciences, Waseda University, Saitama, Japan, 3. Lab. of Environmental Brain Science, Faculty of Human Sciences, Waseda University, Saitama, Japan)

^○Tomoka HATTORI¹, Haruka SAHASHI¹, Kouki HARA¹, Haruka SHIMODA¹, Yuuna SADAKA¹, Midori SODA¹, Hironao NAKAYAMA², Hiroaki MURASE³, Kiyoyuki KITAICHI¹ (1. Lab.of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan, 2. Department of Medical Science and Technology, Faculty of Health Sciences, Hiroshima International University, Higashihiroshima, Japan, 3. Glovia Co., Ltd, Tokyo, Japan)

^○Katsunori AZUMA¹, Meriem HADDAR¹, Kyousuke UNO², Shin-ichi MURAMATSU^{3, 4}, Atsumi NITTA¹ (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Laboratory of molecular pharmacology faculty of pharmaceutical sciendes, University of Setsunan, Osaka, Japan, 3. Division of Neurology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan, 4. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Tadashi SAIGUSA¹, Yuri AONO¹, Manabu ISHIKAWA², Masataka KIMURA³ (1. Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Chiba, Japan, 2. Department of Anesthesiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan, 3. Department of Removal Prosthodontics, Nihon University School of Dentistry at Matsudo, Chiba, Japan)

^○Makoto TSUDA¹, Ryoichi TASHIMA¹, Keisuke KOGA¹, Hiromu YAWO², Hidemasa FURUE³ (1. Department of Life Innovation, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan, 2. Department of Developmental Biology and Neuroscience, Tohoku University Graduate School of Life Sciences, Miyagi, Japan, 3. Department of Neurophysiology, Hyogo College of Medicine, Hyogo, Japan)

^○Yu MIYAHARA, Hideki FUNAHASHI, Ayaka HARUTA-TSUKAMOTO, Kosuke EBIHARA, Toshikazu NISHIMORI, Yasushi ISHIDA (Department of Psychiatry, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan)

^○Naoki YAMAUCHI, Hiroshi NOMURA, Taiju AMANO, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)

^○Hiroe SUZUKI, Natsuko HITORA-IMAMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)

^○Yu-Ting CHU¹, Sih-Ting LUO¹, Hsin-Yi CHUNG¹, Iona MACDONALD¹, Jaung-Geng LIN², Tsung-Jung HO^{3, 4}, Pei-Hsuan SHEN⁵, Yi-Hung CHEN¹ (1. Graduate Institute of Acupuncture Science, China Medical University,Taichung, Taiwan, 2. School of Chinese Medicine, China Medical University, Taichung, Taiwan., 3. Department of Chinese Medicine, Hualien Tzu Chi Hospital, Hualien, Taiwan., 4. School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan, 5. Division of Chinese Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan)

^○Yuri AONO¹, Yuriko WATANABE², Tadashi SAIGUSA¹ (1. Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Chiba, Japan, 2. Department of Oral Surgery, Nihon University School of Dentistry at Matsudo, Chiba, Japan)

^○Yoshihiko KOSAKI^{1, 2}, Daisuke NISHIZAWA¹, Hideko ARITA³, Kazuo HANAOKA³, Choku YAJIMA³, Masako ISEKI⁴, Jitsu KATO⁵, Setsuro OGAWA⁶, Ayako HIRANUMA^{1, 7}, Shinya KASAI¹, Junko HASEGAWA¹, Kyoko NAKAYAMA¹, Yuko EBATA¹, Yoshihiko KOUKITA², Tatsuya ICHINOHE², Masakazu HAYASHIDA^{1, 4, 8}, Ken-ichi FUKUDA⁹, Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Dental Anesthesiology, Tokyo Dental College, Tokyo, Japan, 3. Department of Anesthesiology and Pain Relief Center, JR Tokyo General Hospital, Tokyo, Japan, 4. Department of Anesthesiology & Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan, 5. Department of Anesthesiology, Nihon University School of Medicine, Tokyo, Japan, 6. Nihon University University Research Center, Tokyo, Japan, 7. Department of Surgery, Toho University Sakura Medical Center, Sakura, Japan, 8. Department of Anesthesiology, Saitama Medical University International Medical Center, Hidaka, Japan, 9. Department of Oral Health and Clinical Science, Tokyo Dental College, Tokyo, Japan)

^○Rie INOUE^{1, 2}, Daisuke NISHIZAWA¹, Junko HASEGAWA¹, Kyoko NAKAYAMA¹, Ken-ichi FUKUDA³, Hiroyuki SUMIKURA², Masakazu HAYASHIDA^{1, 2, 4}, Kazutaka IKEDA¹ (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Anesthesiology & Pain Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan, 3. Department of Oral Health & Clinical Science, Tokyo Dental College, Tokyo, Japan, 4. Department of Anesthesiology, Saitama Medical University International Medical Center, Hidaka, Japan)

^○Moe SOEDA^{1, 2}, Seii OHKA¹, Daisuke NISHIZAWA¹, Manabu SUNO³, Ken-ichi FUKUDA², Tatsuya ICHINOHE⁴, Kazutaka IKEDA⁴ (1. Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Oral Health and Clinical Science, Tokyo Dental College, Tokyo, Japan, 3. Graduate School of Medicine Dentistry and Pharmaceutical science, Okayama University, Okayama, Japan, 4. Department of Dental Anesthesiology, Tokyo Dental College, Tokyo, Japan)

^○Hidetoshi TAGE, Haruka SHIMODA, Aoi GOSHIMA, Suguru ITO, Midori SODA, Kiyoyuki KITAICHI (Lab. of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan)

^○Fumiko SEKIGUCHI, Rika YAMASHITA, Hiroki YASUI, Atsufumi KAWABATA (Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University)

^○Maho TSUBOTA¹, Ryotaro FUKUDA¹, Yusuke HAYASHI¹, Takaya MIYAZAKI¹, Shin UEDA¹, Masahiro NISHIBORI², Atsufumi KAWABATA¹ (1. ​Laboratory of Pharmacology and Pathophysiology Faculty of Pharmacy, Kindai University, Osaka, Japan, 2. Department of Pharmacology, Okayama University Graduate School of Medicine, Okayama, Japan)

^○Yuya IKEDA¹, Takaya MIYAZAKI¹, Maho TSUBOTA¹, Shiori TOMITA¹, Fumiko SEKIGUCHI¹, Masahiro NISHIBORI², Atsufumi KAWABATA¹ (1. Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Osaka, Japan, 2. Department of Pharmacology, Okayama University Graduate School of Medicine, Okayama, Japan)

^○Seon-Cheol PARK¹, Jinseon KIM², Daeho KIM³ (1. Department of Psychiatry, Inje University College of Medicine, 2. Department of Epidemiology, Graduate School of Public Health, Seoul National University, South Korea, 3. Department of Psychiatry, Hanyang University Guri Hospital, Guri, Republic of Korea)

^○Tsuyoshi SASAKI^{1, 2}, Kenji HASHIMOTO³, Yutaka HOSODA^{1, 2}, Yasunori ODA², Tomihisa NIITSU², Yuko FUJITA³, Yohei KAWASAKI⁴, Nobuhisa KANAHARA³, Akihiro SHIINA³, Tasuku HASHIMOTO², Masaomi IYO^{1, 2, 3} (1. Department of Child Psychiatry, Chiba-University Hospital, 2. Department of Psychiatry, Graduate School of Medicine, Chiba University, 3. Chiba University Center for Forensic Mental Health, 4. Biostatistics Section, Clinical Research Center, Chiba University Hospital)

^○Rie ISHIKAWA¹, Chiaki UCHIDA¹, Shiho KITAOKA², Tomoyuki FURUYASHIKI², Satoshi KIDA^{1, 3} (1. Department of bioscience, Tokyo University of Agriculture, Tokyo, Japan, 2. Division of Pharmacology, Kobe University Graduate School of Medicine, Hyogo, Japan, 3. Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan)

^○Katsumasa SOGO, Masanobu SOGO, Yoshie OKAWA (SOGO PTSD INSTIRUTE in sogo clinic, Hiroshima, Japan)

^○Young-Hoon KO¹, Kyu-Man HAN² (1. Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea, 2. Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea)

^○Shinya WATANABE, Hidehiro UMEHARA, Yukiko TOMIOKA, Makoto KINOSHITA, Masahito NAKATAKI, Shusuke NUMATA, Tetsuro OHMORI (Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School)

^○Kotaro HATTA¹, Hana HASEGAWA², Atsushi IMAI³, Yasuhiko SUDO⁴, Fumiyoshi MORIKAWA⁵, Shigemasa KATAYAMA⁶, Haruo WATANABE⁷, Takuya ISHIZUKA⁸, Mitsuru NAKAMURA⁹, Fuminari MISAWA¹⁰, Kiyoshi FUJITA¹¹, Shigeru OZAKI¹², Kentaro UMEDA³, Hiroyuki NAKAMURA¹³, Yutaka SAWA⁷, Naoya SUGIYAMA² (1. Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, Japan, 2. Department of Psychiatry, Numazu Chuo Hospital, Tokyo, Japan, 3. Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan, 4. Department of Psychiatry, Tosa Hospital, Tokyo, Japan, 5. Department of Psychiatry, Asahikawa Keisenkai Hospital, Tokyo, Japan, 6. Department of Psychiatry, Seijin Hospital, Tokyo, Japan, 7. Department of Psychiatry, Sawa Hospital, Tokyo, Japan, 8. Department of Psychiatry, Hasegawa Hospital, Tokyo, Japan, 9. Department of Psychiatry, Narimasu Kosei Hospital, Tokyo, Japan, 10. Department of Psychiatry, Yamanashi Prefectural Kita Hospital, Tokyo, Japan, 11. Department of Psychiatry, The Okehazama Hospital, Tokyo, Japan, 12. Department of Psychiatry, Toshima Hospital, Tokyo, Japan, 13. Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Science, Tokyo, Japan)

^○Tomihisa NIITSU¹, Tatsuki HATA^{1, 2}, Masahiko NISHIMOTO³, Yutaka HOSODA^{2, 4}, Ryota SEKI^{1, 5}, Atsushi KIMURA¹, Yasunori ODA¹, Yohei KAWASAKI⁶, Tasuku HASHIMOTO^{1, 7}, Masatomo ISHIKAWA¹, Nobuhisa KANAHARA^{1, 8}, Masaomi IYO^{1, 4, 8}, - THE ROADS STUDY GROUP¹ (1. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan, 2. Fujita Hospital, Sosa, Chiba, Japan, 3. Soshu Hospital, Atsugi, Kanagawa, Japan, 4. Child Psychiatry, Chiba University Hospital, Chiba, Japan, 5. Chiba Hospital, Funabashi, Chiba, Japan, 6. Clinical Research Center, Chiba University Hospital, Chiba, Japan, 7. Sodegaura-Satsukidai Hospital, Sodegaura, Chiba, Japan, 8. Division of Medical Treatment and Rehabilitation, Center for Forensic Mental Health, Chiba University, Chiba, Japan)

Saidah SYAMSUDDIN, Faisal IDRUS, ^○Andi Fatimah YUNIASARI, Andi Jayalangkara TANRA, Sonny Teddy LISAL (University of Hasanuddin)

^○Saeheon JANG (Department of psychiatry, Bongseng Memorial Hospital)

^○Won-Myong BAHK¹, Young Sup WOO¹, Bo-Hyun YOON², Bong-Hee JEON², Jeong Seok SEO³, Beomwoo NAM³, Sang-Yeol LEE⁴, Young-Myo JAE⁵, Sae-Heon JANG⁵, Hun Jeong EUN⁶, Seung-Hee WON⁷, Kwanghun LEE⁸, Jonghun LEE⁹, Moon-Doo KIM¹⁰ (1. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, 2. Department of Psychiatry, Naju National Hospital, Naju, 3. Department of Psychiatry, Konkuk University School of Medicine, Chungju, 4. Department of Psychiatry, School of Medicine, Wonkwang University, Iksan, 5. Department of Psychiatry, Bongseng Memorial Hospital, Busan, 6. Department of Neuropsychiatry, Presbyterian Medical Center-Jesus Hospital, Jeonju, 7. Department of Psychiatry, School of Medicine, Kyungpook National University, Daegu, 8. Department of Psychiatry, College of Medicine, Dongguk University, Gyeongju, 9. Department of Psychiatry, School of Medicine, Catholic University of Daegu, Daegu, 10. Department of Psychiatry, Jeju National University Hospital, Jeju)

^○Ross BAKER¹, Simon Nitschky SCHMIDT², Pedro SUCH², Peter HERTEL², Jessica MADERA¹ (1. Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, USA, 2. H. Lundbeck A/S, Valby, Denmark)

^○Ross BAKER¹, Cathy ZHAO¹, Anna ERAMO², Timothy PETERS-STRICKLAND¹, Robert MCQUADE¹ (1. Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, USA, 2. H. Lundbeck A/S, Valby, Denmark)

^○Catherine WEISS¹, Stine Rasmussen MEEHAN², John OUYANG³, Mary HOBART¹ (1. Department of Medical Affairs, Otsuka Pharmaceutical Development & Commercialization Inc., 2. Department of Medical Affairs Psychiatry, H. Lundbeck A/S, 3. Department of Biostatistics, Otsuka Pharmaceutical Development & Commercialization Inc.)

^○Catherine WEISS¹, Erin MACKENZIE², Francois THERRIEN³, Peter ZHANG⁴, Stine Rasmussen MEEHAN⁵ (1. Department of Medical Affairs, Otsuka Pharmaceutical Development & Commercialization Inc., 2. Department of Medical Affairs, Lundbeck Canada Inc., 3. Department of Medical Affairs, Otsuka Canada Pharmaceutical Inc., 4. Department of Biostatistics, Otsuka Pharmaceutical Development & Commercialization Inc, 5. Department of Medical Affairs Psychiatry, H. Lundbeck A/S)

^○Kentaro TAKAI¹, Masaomi IYO², Jun ISHIGOOKA³, Masatoshi NAKAMURA¹, Reiko SAKAGUCHI¹, Keisuke OKAMOTO¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. Chiba University Graduate School of Medicine, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Nan-Ying CHIU^{1, 2}, Cheng-Ju CHANG¹, Jeng-Fang LIN¹, Lin-Chi CHIU¹, Wen-Yu HSU², Ting-Gang CHANG², Tzu-Yun YANG² (1. Department of Psychiatry, Evergreen Campus, Lugang Christian Hospital, 2. Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan)

^○Masahiro TAKESHIMA, Kazuo MISHIMA (Department of Neuropsychiatry, Akita University Graduate School of Medicine)

^○Mitsuhiro MIYASHITA, Kazuya TORIUMI, Kazuhiro SUZUKI, Yasue HORIUCHI, Akane YOSHIKAWA, Akiko KOBORI, Masanari ITOKAWA, Makoto ARAI (Project for Schizophrenia Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)

^○Kumiko FUJII¹, Masamitsu MAEKAWA², Yuji OZEKI³, Yoshikatsu ETO⁴, Takahiro SAITO⁵, Masataka SHINOZAKI¹, Yosefu ARIME⁶, Takahide NAGASHIMA^{7, 8}, Hiroaki OKAYASU¹, Kazutaka SHIMODA¹ (1. Department of Psychiatry, Dokkyo Medical University School of Medicine, 2. Pharmaceutical Sciences, Tohoku University Hospital, 3. Department of Psychiatry, Shiga University of Medical Science, 4. Advanced Clinical Research Center, Institute for Neurological Disorders, 5. Yokohama Camellia Hospital, 6. Center for Research Support, Dokkyo Medical University School of Medicine, 7. Department of Neurology, Japanese Red Cross Ashikaga Hospital, 8. Department of Neurology, Dokkyo Medical University School of Medicine)

^○Shin KUROSE¹, Yu MIMURA¹, Hiroyuki UCHIDA¹, Keisuke TAKAHATA², Euitae KIM³, Takefumi SUZUKI⁴, Masaru MIMURA¹, Hiroyoshi TAKEUCHI¹ (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, Chiba, Japan, 3. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea, 4. Department of Neuropsychiatry, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan)

^○Yutaro SHIMOMURA¹, Yuhei KIKUCHI¹, Takefumi SUZUKI³, Hiroyuki UCHIDA^{1, 2}, Masaru MIMURA¹, Hiroyoshi TAKEUCHI^{1, 4} (1. Keio University, School of Medicine, Department of Neuropsychiatry, Tokyo, Japan, 2. Centre for Addiction and Mental Health, Geriatric Mental Health Program, Toronto, Canada, 3. Department of Neuropsychiatry, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan, 4. Centre for Addiction and Mental Health, Toronto, Canada)

^○Ji-Yu LIN, Pei-Chuan WU (Department of Psychiatry, Far Eastern Memorial Hospital, Taiwan)

^○Innawati JUSUP¹, Irena Aryani PUSPOWARDOJO² (1. Psychiatric Department, Faculty of Medicine, Diponegoro University, 2. Faculty of Medicine, Diponegoro University)

^○Nan-Ying CHIU^{1, 2}, Shu-Hui HU¹, Cheng-Ju CHANG¹, Ting-Gang CHANG², Wen-Yu HSU² (1. Department of Psychiatry, Evergreen Campus, Lugang Christian Hospital, 2. Department of Psychiatry, Changhua Christian Hospital, Changhua City, Taiwan )

^○Ha-Ran JEONG, Yu-Ran JEONG, Su-Hee PARK, Hyun-Ju YUN, Young-Hwa SEA, Hangoeunbi KANG (Department of Psychiatry, Naju National Hospital)

^○Junji UNO (Okehazama Hospital Fujita Kokoro Care Center)

^○Jeongwan HONG¹, Sang-Yeol LEE² (1. Iksan Hospital, 2. Wonkwang University School of Medicine and Hospital)

^○Jungsuk LEE¹, Beomwoo NAM², Chan-Hyung KIM³ (1. Department of Psychiatry, National Health Insurance Service Ilsan Hospital, Goyang, Korea, 2. Department of Psychiatry, Konkuk University School of Medicine, Chungju, Korea, 3. Institute of Behavioral Science in Medicine and Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea)

^○Yuzuru KATAOKA¹, Kazutaka OHI^{1, 2}, Takamitsu SHIMADA¹, Hiroaki OKUBO¹, Takashi UEHARA¹, Yasuhiro KAWASAKI¹ (1. Department of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan, 2. Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan)

^○Takamitsu SHIMADA^{1, 2}, Kazutaka OHI^{1, 3}, Yuzuru KATAOKA¹, Yoko KOIDE¹, Hiroaki OKUBO¹, Takashi UEHARA¹, Yasuhiro KAWASAKI¹ (1. Department of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan, 2. Okabe Hospital, Ishikawa, Japan, 3. Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan)

^○Young-Min PARK (Department of Psychiatry, Inje University College of Medicine)

^○Young-Eun OH^{1, 2}, Vishwanath Vasudev PRABHU^{1, 2}, Thong Ba NGUYEN^{1, 2}, Fatimazahra RAMI^{1, 2}, Young-Chul CHUNG^{1, 2} (1. Department of Psychiatry, Chonbuk National University Medical School, Jeonju, South Korea, 2. Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, South Korea)

^○Hikaru KOIZUMI^{1, 3}, Kaoruko AICHI¹, Akihiro MOURI^{4, 5}, Toshitaka NABESHIMA^{5, 6}, Hideaki SOYA^{1, 2} (1. Laboratory of Exercise Biochemistry and Neuroendocrinology, Faculty of Health and Sport Sciences, University of Tsukuba, Japan, 2. Department of Sports Neuroscience, Advanced Research Initiative for Human High Performance (ARIHHP), Faculty of Health and Sport Sciences, University of Tsukuba, 3. The Japan Society for the Promotion of Science, 4. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Aichi, Japan, 5. Japanese Drug Organization of Appropriate Use and Research, Nagoya, Japan, 6. Advanced Diagnostic System Research Laboratory, Graduate School of Health Sciences, Fujita Health University, Aichi, Japan)

^○Marco Andrea RIVA ¹, Paola BRIVIO¹, Giulia SBRINI¹, Maria Serena PALADINI², Vittoria SPERO², Mariusz PAPP³, Raffaella MOLTENI², Francesca CALABRESE¹ (1. Department of pharmacological and biomolecular sciences, University of Milan, 2. Department of Medical Biotechnologies and Translational Medicine, University of Milan, 3. Institute of Pharmacology, Polish Academy of Sciences, Krakow)

^○Hisayoshi KUBOTA¹, Akihiro MOURI¹, Kazuo KUNISAWA¹, Moe NIIJIMA¹, Mami HIRAKAWA¹, Yuko MORI², Yasuko YAMAMOTO², Toshitaka NABESHIMA³, Kuniaki SAITO^{2, 3} (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan., 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan.)

^○Kohei TAKAHASHI^{1, 2}, Osamu NAKAGAWASAI¹, Wakana SAKUMA¹, Wataru NEMOTO¹, Takayo ODAIRA¹, Jia-Rong LIN¹, Hiroshi ONOGI³, Lalit K. SRIVASTAVA⁴, Minoru TSUJI², Hiroshi TAKEDA², Koichi TAN-NO¹ (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Miyagi, Japan, 2. Department of Pharmacology, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan., 3. Faculty of Health Science, Tohoku Fukushi University, Miyagi, Japan., 4. Department of Psychiatry, Douglas Mental Health Universit Institute, McGill University, Montreal, Canada)

^○Kazuya TORIUMI¹, Kazuhiro SUZUKI^{1, 2}, Mai ASAKURA¹, Mitsuhiro MIYASHITA¹, Yasue HORIUCHI¹, Akiko KOBORI¹, Masanari ITOKAWA¹, Makoto ARAI¹ (1. Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Psychiatry, Shinshu University School of Medicine)

^○Atsuko HAYATA^{1, 2}, Harui KIJIMA², Yusuke SHINTANI², Takanobu NAKAZAWA^{2, 3}, Hitoshi HASHIMOTO^{1, 2, 4, 5} (1. Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, 2. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 3. Depertment of Pharmacology, Graduate School of Dentistry, Osaka University, 4. Instisute for Datability Science, Osaka University, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University)

^○Atsumi NITTA¹, Kohei HAMATANI¹, Ryo INAGAKI¹, Kequan FU¹, Yuki OKETANI², Kenji SATO², Youta TORII², Chikako HABUCHI², Sekiguchi HIROTAKA², Shuji IRITANI², Norio OZAKI², Shin-ichi MURAMATSU^{3, 4}, Yoshiaki MIYAMOTO¹ (1. Dept of Pharmaceutical Thera and Neuropharmacol, Fac of Pharmaceutical Sci. Grad Sch of Med and Pharm Sci.University of Toyama, Toyama, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 3. Division of Neurological Gene Therapy, Open Inovation Center, Jichi Medical University,Shimotsuke, Japan, 4. Center for Gene and Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Tomoyuki MURANO, Hideo HAGIHARA, Tsuyoshi MIYAKAWA (Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University)

^○Marco Andrea RIVA ¹, Francesca MARCHISELLA¹, Maria Serena PALADINI², Veronica BEGNI¹, Paola BRIVIO¹, Vittoria SPERO², Francesca CALABRESE¹, Raffaella MOLTENI² (1. Department of pharmacological and biomolecular sciences, University of Milan , 2. Department of Medical Biotechnologies and Translational Medicine, University of Milan)

^○Wataru UKAI¹, Yoshiyasu KIGAWA¹, Eri HASHIMOTO¹, Kenta DERIHA¹, Hanako HASHIGUCHI¹, Emi NISHIMURA¹, Masaya TAYAMA^{1, 2}, Kengo FURUSE¹, Takao ISHII¹, Marco A. RIVA³, Chiaki KAWANISHI¹ (1. Department of Neuropsychiatry, School of Medicine, Sapporo Medical University, Sapporo, Japan, 2. Psychiatry Institute, Hokujinkai Medical Corporation, Sapporo Japan, 3. Department of Pharmacological Sciences, University of Milano, Milan, Italy)

^○Yanhong PIAO¹, Young-Eun OH², Fatima Zahra RAMI², Chul Chung YOUNG^{1, 3} (1. Department of Psychiatry, Chonbuk National University Hospital, Jeonju, Korea, 2. Department of Medical Science, Chonbuk National University, Jeonju, Korea, 3. Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea)

^○Kristanty Randa ARUNG¹, Andi Jayalangkara TANRA², Syafari Daniel MANGOPO¹ (1. RSUD Lakipadada, 2. Hasanuddin University)

^○Junhee LEE¹, Youngwoo Bryan YOON², Kang Ik Kevin CHO³, Seongho SEO⁴, Jae Sung LEE⁵, Jae Min JEONG⁵, Minah KIM¹, Tae Young LEE¹, Jun Soo KWON^{1, 6} (1. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea, 2. Department of Psychiatry, Washington University in St. Louis, MO, USA, 3. Psychiatry Neuroimaging Laboratory, Harvard Medical School, MA, USA, 4. Department of Neuroscience, Gachon University College of Medicine, Incheon, Korea, 5. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea, 6. Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea)

^○Ryosuke TARUMI^{1, 2}, Sakiko TSUGAWA¹, Yoshihiro NODA¹, Plitman ERIC^{3, 4}, Shiori HONDA⁵, Karin MATSUSHITA⁶, Sofia CHAVEZ ⁷, Kyosuke SAWADA¹, Masataka WADA¹, Mie MATSUI⁸, Shinya FUJII⁶, Takahiro MIYAZAKI¹, Mallar CHAKRAVARTY^{3, 4, 9}, Hiroyuki UCHIDA^{1, 7}, Gary REMINGTON^{7, 10}, Ariel GRAFF-GUERRERO^{7, 10}, Masaru MIMURA¹, Shinichiro NAKAJIMA^{1, 7} (1. Department of Neuropsychiatry Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, Komagino Hospital, 3. Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montreal, Canada, 4. Department of Psychiatry, McGill University, Montreal, Canada, 5. Faculty of Environment and Information Studies, Keio University, 6. Faculty of Environment and Information Studies, Keio University, 7. Campbell Institute Research Program, Centre for Addiction and Mental Health, Toronto, Canada, 8. Department of Clinical Cognitive Neuroscience, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan, 9. Department of Biomedical Engineering, McGill University, Montreal, Canada, 10. Department of Psychiatry, University of Toronto, Toronto, Canada)

^○Masashi OHTA¹, Masahito NAKATAKI¹, Tomoya TAKEDA¹, Shusuke NUMATA¹, Takeo TOMINAGA¹, Naomi KAMEOKA², Hiroko KUBO¹, Makoto KINOSHITA¹, Kanae MATSUURA², Maki OHTOMO³, Naoya TAKEICHI⁴, Masafumi HARADA³, Tetsuro OHMORI¹ (1. Department of Psychiatry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan, 2. Department of Psychiatry, Tokushima University Hospital, Tokushima, Japan, 3. Department of Radiology and Radiation Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan, 4. Department of Radiology, Tokushima University Hospital, Tokushima, Japan)

^○Naohisa TSUJINO^{1, 2}, Hiromi TAGATA¹, Mayu ONOZATO³, Tatsuya SAKAMOTO³, Tomoyuki FUNATOGAWA¹, Itsuki KIMURA⁴, Naoyuki KATAGIRI¹, Taiju YAMAGUCHI¹, Takahiro NEMOTO¹, Takeshi FUKUSHIMA³, Masafumi MIZUNO¹ (1. Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, Saiseikai Yokohamashi Tobu Hospital, Kanagawa, Japan, 3. Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan , 4. Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)

^○Silvia Kyungjin LHO^{1, 2}, Minah KIM^{1, 2}, Tak Hyung LEE³, Yoo Bin KWAK³, Jun Soo KWON^{1, 2, 3} (1. Department of Psychiatry, Seoul National University College of Medicine, 2. Department of Neuropsychiatry, Seoul National University Hospital, 3. Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences)

^○Guangfan SHEN¹, Woo-Sung KIM², Congcong LIU³, Young-Chul CHUNG⁴ (1. Department of Psychiatry, Chonbuk National University Hospital, Jeonju, Korea, 2. Department of Medical Science, Chonbuk National University, Jeonju, Korea, 3. Department of Medical Science, Chonbuk National University, Jeonju, Korea, 4. Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea)

^○Junya FUJINO^{1, 2}, Shisei TEI^{1, 2, 3, 4}, Kimito HIROSE², Ryosaku KAWADA², Kosuke TSURUMI², Noriko MATSUKAWA², Jun MIYATA², Genichi SUGIHARA^{2, 5}, Yujiro YOSHIHARA², Nobumasa KATO¹, Toshiya MURAI², Hidehiko TAKAHASHI^{1, 2, 5} (1. Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. Institute of Applied Brain Sciences, Waseda University, Saitama, Japan, 4. School of Human and Social Sciences, Tokyo International University, Saitama, Japan, 5. Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan)

^○Hiroyuki KAMEI¹, Ippei TAKEUCHI², Yui YAMADA¹, Yuichiro HORII¹, Manako HANYA¹, Junji UNO², Kiyoshi FUJITA² (1. Lab. of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2. Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, Japan)

^○Wen Yin CHEN^{1, 2}, Sheng Jean HUANG^{3, 4}, Chun Hung PAN¹, Tien Wey YANG^{1, 5, 6}, Chian Jue KUO^{1, 5, 6, 7} (1. Department of psychiatry, Songde branch, Taipei City Hospital, 2. Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan, 3. Taipei City Hospital, Taipei, Taiwan, 4. Department of Surgery, College of Medicine, National Taiwan University, Taipei, Taiwan, 5. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 6. Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan, 7. Department and Graduate Institute of Forensic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan)

^○Mutsuki SAKUMA^{1, 2, 3} (1. National Hospital Organization, Kurihama Medical and Addiction Center, Kanagawa, Japan, 2. Department of Neuropsychiatry, Yamanashi Prefectural Kita Hospital, Yamanashi, Japan, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Sun-Young MOON^{1, 2}, Minah KIM^{1, 2}, Tae Young LEE^{1, 2}, Jun Soo KWON^{1, 2, 3} (1. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea, 2. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea, 3. Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea)

^○Kazuhiro SUZUKI^{1, 2}, Kazuya TORIUMI¹, Mitsuhiro MIYASHITA¹, Akane YOSHIKAWA¹, Yasue HORIUCHI¹, Shin KOIKE³, Yuki OGASAWARA³, Masahiro ITOKAWA¹, Shinsuke WASHIZUKA², Makoto ARAI¹ (1. Project for Schizophrenia Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of psychiatry,Shinshu University, Nagano, Japan, 3. Department of Analytical Biohemistry, Meiji Pharmaceutical University, Tokyo, Japan)

^○Pornjira PARIWATCHARAKUL¹, Theenida WANNAKOWAT² (1. Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2. Hatyai Hospital, Songkhla, Thailand)

^○An-Nie CHUNG, Shih-Ku LIN (Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan)

^○Nan-Ying CHIU^{1, 2}, Shu-Hui HU¹, Pei-Ju TSAI² (1. Department of Psychiatry, Evergreen Campus, Lugang Christian Hospital, 2. Department of Psychiatry, Changhua Christian Hospital, Changhua City, Taiwan)

^○Yuhei KIKUCHI^{1, 2}, Yutaro SHIMOMURA^{1, 3}, Hiroyuki UCHIDA¹, Takefumi SUZUKI⁴, Masaru MIMURA¹, Hiroyoshi TAKEUCHI¹ (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, Komagino Hospital, Tokyo, Japan, 3. Department of Psychiatry, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan, 4. Department of Neuropsychiatry, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan)

^○Sangyeol LEE¹, Seung-Ho JANG¹, Jeong-Wan HONG² (1. Department of Psychiatry, Wonkwang University School of Medicine and Hospital, 2. Department of Psychiatry, Iksan General Hospital)

^○Chien-Chen Jean HUANG^{1, 2}, Yu-Cih YANG³, Yi-Hung CHEN⁴ (1. Graduate Institute of Chinese Medicine, China Medical University, 2. Department of Traditional Chinese Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan, 3. Management office for Health Data, China Medical University Hospital, Taichung, Taiwan, 4. Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan)

^○Dong Ho LEE¹, So-Won KIM¹, Sang-Yeol LEE¹, Han-Seung RYU², Suck-Chei CHOI², Seung-Ho RHO¹, Seung-Ho JANG¹ (1. Departments of Psychiatry, School of Medicine, Wonkwang University, Iksan, Korea, 2. Departments of Internal Medicine, Wonkwang University, Iksan, Korea)

^○Kotaro HATTORI^{1, 2}, Yuuki YOKOTA^{1, 2}, Ryo MATSUMURA¹, Sumiko YOSHIDA¹, Yu-ichi GOTO¹, Hiroshi KUNUGI² (1. Medical Genome Center, National Center of Neurology and Psychiatry, 2. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

^○Masanari ITOKAWA^{1, 2} (1. Tokyo Metropolitan Institute of Medical Science, 2. Tokyo Metropolitan Matsuzawa Hospital)

^○Haruhide KIMURA (Neuroscience Drug Discovery Unit, Research, Takeda Parmaceutical Company Limited)

^○Kazuki YABUUCHI¹, Kenneth KOBLAN², Robert GOLDMAN², Justine KENT², Seth HOPKINS², Antony LOBEL² (1. Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceutical Inc.)

^○Hidenori YAMASUE (Department of Psychiatry, Hamamatsu University School of Medicine)

^○Toshihiko MATSUMOTO¹, Hiroko KOTAJIMA-MURAKAMI^{1, 2}, Ayumi TAKANO³, Yasukazu OGAI⁴, Daisuke FUNADA^{1, 5}, Yuko TANIBUCHI^{1, 6}, Hisateru TACHIMORI⁷, Kazushi MARUO⁸, Kazutaka IKEDA^{1, 2} (1. Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 3. Department of Mental Health and Psychiatric Nursing Tokyo Medical and Dental University, 4. Social Psychiatry and Mental Health, Faculty of Medicine, University of Tsukuba, 5. Department of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, 6. Department of Psychiatry, Chiba Hospital, 7. Department of Clinical Research Promotion, Transrational Medical Center, National Center of Neurology and Psychiatry, 8. Department of Biostatistics, Faculty of Medicine, University of Tsukuba)

^○Hiroko ONO¹, Chong ZHANG², Ying XU³, James M O’DONNELL^{2, 3}, Hidekuni YAMAKAWA¹, Naotaka HORIGUCHI¹, Toshiyuki ASAKI¹, Mark E GURNEY⁴ (1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 2. Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 4. Tetra Discovery Partners Inc.)

^○Eriko NAKATA (Nippon Chemiphar Co., Ltd.)

^○Bjarke EBERT (H. Lundbeck A/S)

^○Shawn K SINGH (VistaGen Therapeutics, Inc.)

^○Yushin TOMINAGA¹, Nagahide TAKAHASHI², Ayako SHIRAISHI¹, Yuka NAMIKAWA¹, Aya YAMADA¹, Yuya YAMADA¹, Toshifusa SHU¹, Hiroko SHIMIZU¹, Peter ZANNIKOS³, Jaskaran SINGH³, David HOUGH³ (1. Janssen Japan R&D, 2. Hamamatsu University School of Medicine, 3. Janssen Research and Development, LLC )

^○Kenji HASHIMOTO (Chiba University Center for Forensic Mental Health, Chiba, Japan)